Mice Model Market - 2024-2031
The Mice Model Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Mice Model Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Type
Both primary and secondary data sources have been used in the global Mice Model Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
A Mice Model Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Type
- Inbred Mice*
- Outbred Mice
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Others
- Breeding *
- Cryopreservation
- Model in-Licensing
- Genetic Testing
- Other
- CRISPR/CAS9*
- Embryonic Stem Cell Injection
- Nuclear Transfer
- Other
- Oncology *
- Cardiovascular Studies
- Neurology
- Other
- Pharmaceutical & Biotechnology Companies *
- Contract Research Organizations (CROs)
- Academic & Research Institutions
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Mice Model Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Type
3.2. Market Snippet by Service
3.3. Market Snippet by Technology
3.4. Market Snippet by Application
3.5. Market Snippet by End User
3.6. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The growth in the advancements in gene editing tools will drive the market growth
4.1.1.2. The growing demand for personalized medicine will drive the market growth
4.1.2. Restraints:
4.1.2.1. Regulations and laws for the ethical use of animals in research will hamper the market growth in the forecast period
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Unmet Needs
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or a Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
7.1.2. Market Attractiveness Index, By Type Segment
7.2. Inbred Mice*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Outbred Mice
7.4. Genetically Engineered Mice
7.5. Hybrid/Congenic Mice
7.6. Others
8. BY SERVICE
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
8.1.2. Market Attractiveness Index, By Service
8.2. Breeding *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Cryopreservation
8.4. Model in-Licensing
8.5. Genetic Testing
8.6. Other
9. BY TECHNOLOGY
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. CRISPR/CAS9*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Embryonic Stem Cell Injection
9.4. Nuclear Transfer
9.5. Other
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Oncology *
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
10.2.3. Cardiovascular Studies
10.2.4. Neurology
10.2.5. Other
11. BY END USER
11.1. Introduction
11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
11.1.2. Market Attractiveness Index, By End User Segment
11.2. Pharmaceutical & Biotechnology Companies *
11.2.1. Introduction
11.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
11.3. Contract Research Organizations (CROs)
11.4. Academic & Research Institutions
11.5. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. The U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. The U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
13. COMPETITIVE LANDSCAPE
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Product Benchmarking
13.4. Key Companies to Watch
13.5. Company with disruptive technology
13.6. Start-Up Companies
14. COMPANY PROFILES
14.1. Jackson Laboratory*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Charles River Laboratories
14.3. genOway
14.4. Aragen Bioscience
14.5. GenOway
14.6. Taconic
14.7. Oragenics Inc
14.8. Innovative
14.9. FENGSHI Group
14.10. Cyanogen (*LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Type
3.2. Market Snippet by Service
3.3. Market Snippet by Technology
3.4. Market Snippet by Application
3.5. Market Snippet by End User
3.6. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The growth in the advancements in gene editing tools will drive the market growth
4.1.1.2. The growing demand for personalized medicine will drive the market growth
4.1.2. Restraints:
4.1.2.1. Regulations and laws for the ethical use of animals in research will hamper the market growth in the forecast period
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Unmet Needs
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or a Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
7.1.2. Market Attractiveness Index, By Type Segment
7.2. Inbred Mice*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.3. Outbred Mice
7.4. Genetically Engineered Mice
7.5. Hybrid/Congenic Mice
7.6. Others
8. BY SERVICE
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
8.1.2. Market Attractiveness Index, By Service
8.2. Breeding *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Cryopreservation
8.4. Model in-Licensing
8.5. Genetic Testing
8.6. Other
9. BY TECHNOLOGY
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. CRISPR/CAS9*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Embryonic Stem Cell Injection
9.4. Nuclear Transfer
9.5. Other
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Oncology *
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
10.2.3. Cardiovascular Studies
10.2.4. Neurology
10.2.5. Other
11. BY END USER
11.1. Introduction
11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
11.1.2. Market Attractiveness Index, By End User Segment
11.2. Pharmaceutical & Biotechnology Companies *
11.2.1. Introduction
11.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
11.3. Contract Research Organizations (CROs)
11.4. Academic & Research Institutions
11.5. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. The U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. The U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
13. COMPETITIVE LANDSCAPE
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Product Benchmarking
13.4. Key Companies to Watch
13.5. Company with disruptive technology
13.6. Start-Up Companies
14. COMPANY PROFILES
14.1. Jackson Laboratory*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. Charles River Laboratories
14.3. genOway
14.4. Aragen Bioscience
14.5. GenOway
14.6. Taconic
14.7. Oragenics Inc
14.8. Innovative
14.9. FENGSHI Group
14.10. Cyanogen (*LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Services
15.3. Contact Us
